MX2008001011A - Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia). - Google Patents

Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia).

Info

Publication number
MX2008001011A
MX2008001011A MX2008001011A MX2008001011A MX2008001011A MX 2008001011 A MX2008001011 A MX 2008001011A MX 2008001011 A MX2008001011 A MX 2008001011A MX 2008001011 A MX2008001011 A MX 2008001011A MX 2008001011 A MX2008001011 A MX 2008001011A
Authority
MX
Mexico
Prior art keywords
control
require
hyperglycaemia
glucose
blood
Prior art date
Application number
MX2008001011A
Other languages
Spanish (es)
Inventor
Ricardo Guadalupe Salazar Leal
Original Assignee
Ricardo Guadalupe Salazar Leal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ricardo Guadalupe Salazar Leal filed Critical Ricardo Guadalupe Salazar Leal
Priority to MX2008001011A priority Critical patent/MX2008001011A/en
Publication of MX2008001011A publication Critical patent/MX2008001011A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention refers to an adjuvant product in the treatment for controlling blood glucose levels, which main characteristics are that it is made of food-grade ingredients so that it may be used by any person requiring it and even by those that do not require it without producing side effects; the product does not require a medical prescription since it is not a drug but a natural supplement, which due to the aforementioned properties, is able to make a positive change in the organism in order to control the disease; in addition, it does not have short-, medium- or long-term side effects according to the studies carried out and attached to the file. The purpose of the present invention is to provide a natural formulation (food supplement) to people requiring a blood glucose level control with the aforesaid characteristics, which may offer an improved life level and quality by means of the disease control.
MX2008001011A 2008-01-22 2008-01-22 Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia). MX2008001011A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX2008001011A MX2008001011A (en) 2008-01-22 2008-01-22 Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia).

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2008001011A MX2008001011A (en) 2008-01-22 2008-01-22 Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia).

Publications (1)

Publication Number Publication Date
MX2008001011A true MX2008001011A (en) 2009-07-22

Family

ID=41559050

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001011A MX2008001011A (en) 2008-01-22 2008-01-22 Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia).

Country Status (1)

Country Link
MX (1) MX2008001011A (en)

Similar Documents

Publication Publication Date Title
PH12018500767A1 (en) Pharmaceutical composition, methods for treating and uses thereof
PH12016500959B1 (en) Use of nutritional compositions having a low protein amount
MX2019012848A (en) Growth differentiation factor 15 (gdf-15) constructs.
MX354875B (en) Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders.
MX2015008114A (en) Exendin-4 Derivatives.
NZ612455A (en) Human milk oligosaccharides to promote growth of beneficial bacteria
JP2017515499A5 (en)
AU2018326364A1 (en) Methods of enhancing and/or stabilizing cardiac function in patients with Fabry disease
EA201401155A1 (en) PREPARATION AND METHOD OF PREVENTION AND TREATMENT OF ATYPICAL OSTEOPOROSIS
WO2015107428A3 (en) Lipidated peptides for lowering blood glucose
RU2009109910A (en) HUMAN BODY CORRECTION METHOD
MX2008001011A (en) Adjuvant formulation for controlling high levels of glucose in blood (hyperglycaemia).
WO2010049590A3 (en) A new pharmaceutical product
CN105285542A (en) Formula of dietary therapy congee for removing liver-fire and improving eyesight
IN2012DN03631A (en)
Mostafa et al. Guiding Recommendations for Feeding the Family a Healthy and Safe Food: The Preventive and Curative Role of Food
Zhi-Jia et al. The correction of the deep superior sulcus after the orbital implantation of hydroxyapatite
CN103494192A (en) Food therapeutic composition for treating ulcer bleeding
WO2007113540A3 (en) Regulating fat and carbohydrate oxidation in muscle tissue comprising controlling carnitine content in muscle
GR20140100596A (en) Pure donkey milk-based noodles
MX2016002865A (en) Nutraceutical for controlling the metabolic syndrome.
PH12019550216A1 (en) Compositions for treatment of hyperglycemia in diabetes mellitus patients
Chen et al. Studying the Impact of Syndrome in TCM Diagnose for Designing Effective Prescription
Joob et al. Aerobic isotonic exercise and Prameha (diabetes mellitus) as per Prakriti
MX2010011446A (en) Improved multivitamin composition and process for the preparation thereof.